Loading organizations...
MPathic is a technology company.
MPathic develops an AI-powered platform designed to enhance human-centered AI safety by analyzing and interpreting conversational and contextual data. The company’s technology utilizes science-backed models, clinical expertise, and high-quality datasets to improve accuracy, elevate trust, and reduce harmful AI responses. MPathic focuses on ensuring the responsible deployment of AI in sensitive applications.
The company was founded in 2021 by Dr. Grin Lord, who also serves as CEO. As a psychologist, Lord identified the crucial need for AI systems to operate safely and ethically, particularly in areas involving human interaction and well-being. This insight led to the creation of MPathic, aiming to embed psychological principles and clinical rigor into AI development.
MPathic's platform serves industries leveraging conversational AI, including healthcare and mental health, where trustworthy and safe interactions are paramount. The company's overarching vision is to be a leading authority in human-centered AI safety, ensuring that artificial intelligence is integrated responsibly across various applications.
MPathic has raised $4.0M across 1 funding round.
MPathic has raised $4.0M in total across 1 funding round.
mpathic is an AI-powered platform specializing in conversation analytics for life sciences, healthcare, and clinical settings. It analyzes conversational and contextual data using machine learning models backed by over a decade of scientific validation, including 200+ human behavior detections and 500k expert-labeled communications, to enhance clinical accuracy, patient safety, and communication outcomes[1][2][5][7]. The company offers products like mTrial, an AI-driven quality assurance tool for optimizing clinical trials through real-time feedback, fidelity analysis, and multi-site monitoring, alongside datasets, red-teaming services, and APIs for AI safety in vulnerable contexts[1][7]. Serving biopharma, healthcare providers, insurers, and surgical training programs, mpathic solves challenges in scaling oversight, reducing bias, and measuring non-technical skills like empathy, with recent achievements including SOC 2 Type II compliance and HIPAA/GDPR adherence[6][7]. Formerly Empathy Rocks and founded in 2021 in Bellevue, Washington, it demonstrates growth through partnerships with entities like Humanly, Seattle Children’s Hospital, and biopharma leaders[1][5][7].
Note: Search results reveal two distinct entities sharing the name "mpathic"—this overview focuses on the AI conversation analytics firm (mpathic.ai), as it aligns with technology innovation in healthcare; a separate contact center services provider (mpathic.com, founded 2020) operates in customer support[3][4].
mpathic.ai emerged in 2021 from the expertise of Dr. Grin Lord, a psychologist and founder/CEO with prior roles as Chief Clinical Officer at Lyssn.io, Clinical Product Psychologist at Youper.ai, and Research Scientist at the University of Washington[1][5]. Her background in generative AI, conversational design, evidence-based therapies, and augmenting human connection via machine learning drove the idea to commercialize gold-standard measures of fidelity in organizational psychology, healthcare, and life sciences[5]. Previously known as Empathy Rocks, the Bellevue, Washington-based startup built on 500k expert-labeled communications and peer-reviewed papers to address gaps in monitoring clinical conversations at scale, especially for patient safety and trial efficiency[1][2][5]. Early traction came from validating AI models against human benchmarks, leading to venture backing and products like mTrial[1][7].
mpathic stands out in AI conversation analytics through:
mpathic rides the AI safety and human-centered analytics wave in healthcare, where generative AI demands rigorous validation for clinical and patient-facing applications amid rising regulatory scrutiny[5][7]. Timing is ideal post-2021 founding, aligning with booming life sciences AI adoption for trials (projected multi-billion market) and needs for scalable oversight amid labor shortages[1][2]. Market forces like HIPAA evolution, bias reduction mandates, and demand for real-time conversational insights favor its niche, influencing the ecosystem by setting benchmarks for "safe" AI—e.g., enabling biopharma to monitor trials ethically and providers to quantify soft skills like empathy[6][7]. It bridges tech and therapy, accelerating digital health revolutions through tools trusted by innovators like Youper.ai alumni[5].
mpathic is poised to expand as AI governance in healthcare tightens, with next steps likely including broader API adoption, international scaling, and integrations for real-time surgical/therapeutic coaching[7]. Trends like multimodal AI (voice, context) and personalized medicine will amplify its edge, potentially evolving it into a standard for clinical AI red-teaming amid growing venture interest[1][5]. Its influence may grow by humanizing AI deployment, tying back to its core mission of expanding understanding through precise, trust-building tech—positioning it as a quiet leader in safer, more empathetic health innovations[2][5].
MPathic has raised $4.0M in total across 1 funding round.
MPathic's investors include Next Frontier Capital, First Row Partners, Full Circle Venture Capital, Graham & Walker, Illuminate Ventures, Portland Seed Fund, WXR Fund.
MPathic has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in June 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 21, 2022 | $4.0M Seed | Next Frontier Capital | First Row Partners, Full Circle Venture Capital, Graham & Walker, Illuminate Ventures, Portland Seed Fund, WXR Fund |